Abstract: Provided are a smart surface, a center console of a vehicle, and a vehicle. The smart surface includes a display device (10), a decorative cover plate (20) including a decorative pattern layer (21), a substrate layer (22), an optical adhesive layer (23), and a glass layer (24) stacked sequentially from top to bottom, an upper surface of the glass layer (24) being fitted to the optical adhesive layer (23), and a lower surface of the glass layer (24) being covered on the display device (10), and an AG fluorescent film (30) fitted to the decorative pattern layer (21), and the AG fluorescent film (30) is used for filtering ambient light or light emitted from the decorative pattern layer (21). The smart surface provided by the present application can reduce the obstruction of the image caused by the decorative pattern by providing the AG fluorescent film.

Abstract: A storage lid for a countertop appliance includes a body that has a first surface and a second surface and includes a raised peripheral wall that is disposed around the first surface and a lid that is disposed around the second surface. An elongated handle extends outwardly from the first surface and defines a recessed channel along the second surface of the body. A tab is operably coupled to the raised peripheral wall of the body. A sealing member is disposed proximate to the lip of the body.

Abstract: Provided herein are methods and systems for identifying chimeric nucleic acid fragments, e.g., organism-pathogen chimeric nucleic acid fragments and chromosomal rearrangement chimeric nucleic acid fragments. Also provided herein are methods and systems relating to determining a pathogen integration profile or a chromosomal rearrangement in a biological sample and determining a classification of pathology based at least in part on a pathogen integration profile or a chromosomal rearrangement in a biological sample. In certain aspects of the present disclosure, cell-free nucleic acid molecules from a biological sample are analyzed.

Abstract: Provided herein are methods and systems for identifying chimeric nucleic acid fragments, e.g., organism-pathogen chimeric nucleic acid fragments and chromosomal rearrangement chimeric nucleic acid fragments. Also provided herein are methods and systems relating to determining a pathogen integration profile or a chromosomal rearrangement in a biological sample and determining a classification of pathology based at least in part on a pathogen integration profile or a chromosomal rearrangement in a biological sample. In certain aspects of the present disclosure, cell-free nucleic acid molecules from a biological sample are analyzed.

Abstract: Techniques are provided for analyzing circular DNA in a biological sample (e.g., including cell-free DNA, such as plasma). For example, to measure circular DNA, cleaving can be performed to linearize the circular DNA so that they may be sequenced. Example cleaving techniques include restriction enzymes and transposases. Then, one or more criteria can be used to identify linearized DNA molecules, e.g., so as to differentiate from linear DNA molecules. An example criterion is mapping a pair of reversed end sequences to a reference genome. Another example criterion is identification of a cutting tag, e.g., associated with a restriction enzyme or an adapter sequence added by a transposase. Once circular DNA molecules (e.g., eccDNA and circular mitochondrial DNA) are identified, they may be analyzed (e.g., to determine a count, size profile, and/or methylation) to measure a property of the biological sample, including genetic properties and level of a disease.

Abstract: Provided herein are methods and systems for identifying chimeric nucleic acid fragments, e.g., organism-pathogen chimeric nucleic acid fragments and chromosomal rearrangement chimeric nucleic acid fragments. Also provided herein are methods and systems relating to determining a pathogen integration profile or a chromosomal rearrangement in a biological sample and determining a classification of pathology based at least in part on a pathogen integration profile or a chromosomal rearrangement in a biological sample. In certain aspects of the present disclosure, cell-free nucleic acid molecules from a biological sample are analyzed.